Journals / Eurasian Journal of Medicine / 2018 / Cilt: 50 - Sayı: 3

Sulfasalazine-Induced Interstitial Fibrosis

Pages
207–209
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years.
📊
Key Findings & Data:Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare.
💡
Conclusion & Impact:Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.

🔖

Cite This Article

SAĞLAM, L., ARAZ, Ö., AKGÜN, M., UÇAR, E. Y., AYDIN, Ö., KERGET, B. (2022). Sulfasalazine-Induced Interstitial Fibrosis. Eurasian Journal of Medicine, Cilt: 50 - Sayı: 3, 207–209. https://ajindex.com/articles/508969

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Ulubaş B, Şahin G, Özer C, Aydın Ö, Özgür E, Apaydın D. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a pa- tient with rheumatoid arthritis. Clin Rheumatol 2004; 23: 249-51. [CrossRef] Meier J, Sturm A. Current treatment of ulcer- ative colitis. World J Gastroenterol 2011; 17: 3204-12.
  2. Hamadeh MA, Atkinson J, Smith LJ. Sulfasalazine- induced pulmonary disease. Chest 1992; 101: 1033-7. [CrossRef] Salloum VK, Ancheril S, Estrada-Y-Martin R. Sul- fasalazine-induced pulmonary disease. CHEST Journal 2005; 128(4_MeetingAbstracts): 447S. Vennera MC, Picado C. Pulmonary manifesta- tions of inflammatory bowel disease. Arch Bron- coneumol 2005; 41: 93-8. [CrossRef]